S-EPMC6462855 - Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes. - OmicsDI

Unknown

Dataset Information

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.

ABSTRACT:

SUBMITTER: Falconi G

PROVIDER: S-EPMC6462855 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature